Latest Edwards Lifesciences Corporation (EW) News on July 12, 2025
Simply Wall St.
17 days ago
Is Edwards Lifesciences Corporation's (NYSE:EW) Stock's Recent Performance A Reflection Of Its Financial Health?
CNW Group
18 days ago
NYSE Content Advisory: Pre-Market update + Wall Street watches the Middle East
MT Newswires
25 days ago
Edwards Lifesciences Insider Sold Shares Worth $673,268, According to a Recent SEC Filing
MT Newswires
a month ago
DBS Bank Adjusts Price Target on Edwards Lifesciences to $78 From $72, Maintains Hold Rating
MT Newswires
a month ago
Leerink Partners Adjusts PT on Edwards Lifesciences to $83 From $77, Maintains Market Perform Rating
Investor's Business Daily
a month ago
How Boston Scientific's Surprise Setback Bolstered Two Of Its Top Rivals
Medical Device Network
2 months ago
Edwards’ study demonstrates value in early aortic stenosis intervention
Investing.com
2 months ago
Citi shuffles MedTech stocks: BDX downgraded, ITGR raised; reiterates top pick
MT Newswires
2 months ago
Citigroup Adjusts Price Target on Edwards Lifesciences to $95 From $84, Maintains Buy Rating
MT Newswires
2 months ago
Piper Sandler Adjusts Price Target on Edwards Lifesciences to $83 From $80, Maintains Overweight Rating
Insider Monkey
2 months ago
Why Edwards Lifesciences (EW) Is Among the Best Medical Device Stocks to Buy Now
Simply Wall St.
2 months ago
Edwards Lifesciences First Quarter 2025 Earnings: EPS Beats Expectations
MT Newswires
2 months ago
Edwards Lifesciences Insider Sold Shares Worth $447,977, According to a Recent SEC Filing
Business Wire
2 months ago
Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference
Simply Wall St.
2 months ago
Edwards Lifesciences (NYSE:EW) Receives FDA Approval For Groundbreaking TAVR Therapy For Asymptomatic Patients
Medical Device Network
2 months ago
FDA approves Edwards’ TAVR system for asymptomatic aortic stenosis patients
MT Newswires
2 months ago
Edwards Lifesciences Gets FDA Approval for TAVR in Asymptomatic Aortic Stenosis
Business Wire
2 months ago
Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis
Insider Monkey
2 months ago
Edwards Lifesciences Corporation (EW): Jim Cramer Says It’s a Hold — But Is Boston Scientific Now His Favorite?
Investor's Business Daily
2 months ago
Dow Jones Aerospace Giant Boeing Nears Buy Point; Spotify Earnings Imminent
MT Newswires
3 months ago
Canaccord Genuity Adjusts Price Target on Edwards Lifesciences to $75 From $71
MT Newswires
3 months ago
UBS Adjusts Price Target on Edwards Lifesciences to $80 From $78, Maintains Neutral Rating
Investor's Business Daily
3 months ago
Edwards Shoots Higher As It Shrugs Off Tariffs Worries — Until 2026
Simply Wall St.
3 months ago
Edwards Lifesciences (NYSE:EW) Projects 2025 Sales Over US$5.7 Billion With Strong Earnings
MT Newswires
3 months ago
Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $89 From $85, Maintains Buy Rating
MT Newswires
3 months ago
Jefferies Adjusts Price Target on Edwards Lifesciences to $73 From $71, Maintains Hold Rating
MT Newswires
3 months ago
Baird Adjusts Price Target on Edwards Lifesciences to $75 From $72, Maintains Neutral Rating
MT Newswires
3 months ago
Piper Sandler Upgrades Edwards Lifesciences to Overweight From Neutral, Adjusts PT to $80 From $73
GuruFocus.com
3 months ago
Edwards Lifesciences Corp (EW) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ...
MT Newswires
3 months ago
Edwards Lifesciences Q1 Adjusted Earnings, Sales Rise; Provides Q2 Guidance
Investor's Business Daily
3 months ago
Why Heart-Focused Edwards Lifesciences Isn't Worried About Tariffs
MT Newswires
3 months ago
Edwards Lifesciences Insider Sold Shares Worth $663,196, According to a Recent SEC Filing
MT Newswires
3 months ago
Truist Cuts Price Target on Edwards Lifesciences to $75 From $78, Keeps Hold Rating
MT Newswires
3 months ago
Citigroup Adjusts Edwards Lifesciences Price Target to $84 From $83, Maintains Buy Rating
Simply Wall St.
3 months ago
Edwards Lifesciences (NYSE:EW) Presents Promising AS Treatment Data At ACC Session
Insider Monkey
3 months ago
Sands Capital Select Growth Fund Sold Edwards Lifesciences Corporation (EW) For Better Opportunities
Insider Monkey
3 months ago
Jim Cramer Calls Edwards Lifesciences (EW) a Hold – Prefers Boston Scientific Right Now!
MT Newswires
3 months ago
Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $85 From $92, Keeps Buy Rating
Insider Monkey
4 months ago
Edwards Lifesciences Corporation (EW): Among the Top Stocks to Buy According to Citadel Investment Group
Simply Wall St.
4 months ago
Edwards Lifesciences Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
Business Wire
5 months ago
Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference
Simply Wall St.
5 months ago
The three-year loss for Edwards Lifesciences (NYSE:EW) shareholders likely driven by its shrinking earnings
MT Newswires
5 months ago
Canaccord Genuity Adjusts Price Target on Edwards Lifesciences to $71 From $68, Maintains Hold Rating
MT Newswires
5 months ago
Daiwa Adjusts Price Target on Edwards Lifesciences to $77 From $72, Maintains Neutral Rating
Investor's Business Daily
5 months ago
Edwards Makes A Bullish Move As Heart-Valve Replacements Top $1 Billion
Insider Monkey
5 months ago
Is Edwards Lifesciences Corporation (EW) the Best Medical Device Stock to Buy?
MT Newswires
5 months ago
Evercore ISI Adjusts Price Target on Edwards Lifesciences to $73 From $75, Keeps In Line Rating
MT Newswires
5 months ago
Wolfe Research Adjusts Price Target on Edwards Lifesciences to $61 From $60, Keeps Underperform Rating
MT Newswires
5 months ago
Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $92 From $90, Keeps Buy Rating
MT Newswires
5 months ago
Morgan Stanley Adjusts Price Target on Edwards Lifesciences to $75 From $70, Keeps Equalweight Rating
MT Newswires
5 months ago